Toronto, ON (March 15, 2024) – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced today the sale of DermLite Holdco I, Inc. (“DermLite”) to FotoFinder Systems Gmbh (“FotoFinder”), a portfolio company of EMZ Partners. DermLite, a portfolio company of DW Healthcare Partners’ Founders Fund, is a California-based company that develops and manufactures dermoscopy tools used by dermatologists and healthcare professionals.  This includes dermatoscopes and phone adapters to enable the trained eye to detect skin cancer and other types of skin conditions through mag ..read more

This marks the third investment in DWHP Founders Fund Toronto, ON and Park City, UT (June 6, 2023) – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announces the completion of its investment in LKC Technologies, Inc. (“LKC”, or the “Company”). LKC manufactures electrophysiology testing devices used as an aid in the diagnosis and management of retinal and optic nerve diseases such as diabetic retinopathy and glaucoma. “We are really looking forward to this partnership with LKC,” said Gabe Becher, Managing Director at DWHP. “We believe the Company is in the early stage ..read more

Park City, UT – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, is pleased to announce the promotion of Eric Moore to Managing Director and Partner. Eric Moore joined DWHP as an Associate in 2012. He was later promoted to Vice President in 2018 and Principal in 2019. Eric briefly departed the firm in 2014 to serve in a senior leadership role at sPower, a leading renewable energy Independent Power Producer. Eric currently serves on multiple DWHP portfolio company Boards. As a Partner in the firm, he will be involved in all aspects of DWHP investing activities including ..read more

Toronto, ON and Park City, UT (March 23, 2023) – DW Healthcare Partners (“DWHP”), a healthcare-focused private equity firm, announced the closing of DW Healthcare Partners Small Cap, L.P. (“Founders Fund”), a fund focused on lower middle market healthcare investments. The fund raised USD $210 million in total capital commitments. This new fund brings DWHP’s total capital under management to USD $1.3 billion. Andrew Carragher, Co-Founder and Managing Partner said, “DWHP has been committed to identifying, building, and scaling small to medium sized healthcare companies for over twenty years. As ..read more

Toronto, ON and Park City, UT (January 3, 2023) –DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announces the completion of its investment in Med Learning Group, LLC (“MLG”, or the “Company”). MLG, previously a division of Ultimate Medical Academy, is a full-service medical education company that holds an Accreditation with ACCME. MLG focuses on developing, implementing, and measuring online and in-person continuing education that improves healthcare practitioners’ ability to provide optimal care to patients. “We are thrilled to be partnering with the team at MLG,” s ..read more

Toronto, ON and Park City, UT (August 30, 2022) – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the closing of its sale of Med-Pharmex Holdings, Inc (“Med-Pharmex”, or the “Company”) to Dechra Pharmaceuticals PLC (“Dechra”). Med-Pharmex is a leading, fully-integrated veterinary pharmaceutical manufacturer focused on developing, manufacturing, and commercializing animal health drugs. “It has been a pleasure to work with Med-Pharmex over the years. Med-Pharmex represents DWHP’s first investment in the animal health space, and since then, we have added three ..read more

Toronto, ON – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, is pleased to announce the promotions of Ronan O’Keane to Principal and Irvin Choo to Vice President. “We recognize the achievements and hard work from both Ronan and Irvin. During their time with the firm, Ronan has played an integral part in growing our investment process and Irvin has worked hard to help many of our portfolio companies. We look forward to their continued leadership and success at the firm.” said Managing Partner, Andrew Carragher. About DW Healthcare Partners DW Healthcare Partners is a ..read more

Park City, UT and Toronto, ON – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, is pleased to announce the promotions of Michael Barulich and Cameron McDavid to Vice President and Adam Sinukoff to Senior Associate. DWHP is also pleased to announce the addition of seven new individuals on the investment team. Joining as Vice President is Mo Gulamhusein and Ronan O’Keane, and as Associate is Brody Wong, Spencer Main, Scott Attwood, Johanna Eisenberg, and Sameer Kandola. “We recognize the achievements of Michael, Cameron, and Adam and look forward to their continued lead ..read more

January 10, 2022 | FOR IMMEDIATE RELEASE Park City, UT and Toronto, ON (January 10, 2022) – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the completion of its investment in Vets Plus, Inc and Noble Pharma, LLC (“Vets Plus “, “Noble”, or the “Company”). Vets Plus is a full-service developer and manufacturer of nutraceutical solutions for the companion animal and livestock markets. Noble is an FDA registered manufacturer of animal health pharmaceuticals. Since 1990, Vets Plus has been a trusted supplier developing uncommonly palatable products for a diverse ..read more

Toronto, ON (December 6, 2021) – DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced today the closing of its sale of WillowWood Global LLC (“WillowWood” or “the Company”) to Blue Sea Capital. WillowWood, a portfolio company of DW Healthcare Partners, is a leading designer and manufacturer of a broad range of prosthetic products. Since 1907, WillowWood has been enabling individuals with limb difference to live their lives to the fullest. DWHP invested in WillowWood in June of 2019 and realized substantial growth in the business through operational improvements a ..read more